Analysis of sequence configurations of the PKR-interacting HCV proteins from plasma and PBMC as predictors of response to interferon-alpha and ribavirin therapy in HIV-coinfected patients.
Bolcic
F
F
Bull
L
L
Martinez
L
L
Reynoso
R
R
Salomon
H
H
Arduino
R
R
Barnett
B
B
Quarleri
J
J
D000998:Antiviral Agents / Q000494:pharmacology* / Q000627:therapeutic use; D004279:DNA, Viral / Q000737:chemistry / Q000235:genetics; D024882:Drug Resistance, Viral; D015658:HIV Infections / Q000150:complications / Q000188:drug therapy*; D016174:Hepacivirus / Q000235:genetics*; D006526:Hepatitis C / Q000150:complications / Q000188:drug therapy* / Q000821:virology*; D006801:Humans; D016898:Interferon-alpha / Q000494:pharmacology* / Q000627:therapeutic use; D010949:Plasma / Q000821:virology; D012254:Ribavirin / Q000494:pharmacology* / Q000627:therapeutic use; D014764:Viral Proteins / Q000235:genetics*
D000998:Antiviral Agents; D004279:DNA, Viral; D016898:Interferon-alpha; D014764:Viral Proteins; D012254:Ribavirin